Price T Rowe Associates Inc Amphastar Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 568,894 shares of AMPH stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
568,894
Previous 583,906
2.57%
Holding current value
$21.8 Million
Previous $23.4 Million
18.2%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$227 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$104 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$81.7 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$74.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$61.8 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.88B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...